An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research published in The Lancet medical journal. The drug lenacapavir passed a critical ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Accurate and ethical journalism on HIV/AIDS plays a vital role in shaping public perceptions, encouraging behavioral change, and raising awareness. Misinformation or vague reporting, however, can ...

Let’s take your partner’s HIV status out of the equation for a moment. You’re looking at a person who has a concerning temper, refuses to admit faults (and, therefore, probably refuses to work on them ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

CAGAYAN DE ORO CITY (PIA) — The Philippine Health Insurance Corporation (PhilHealth) reaffirmed its commitment to supporting ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

A low-income housing cooperative for people with HIV and AIDS is fighting to stay open in San Francisco. On Sunday afternoon, ...

Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...

Dayton & Montgomery County Public Health hosted its ninth annual “Rocking our Red Pumps” event on Friday to recognize ...

SAN FRANCISCO -- At least 400 researchers, physicians, activists, and other concerned citizens gathered here Monday night to ...